Isofol Medical AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 0.721 million compared to SEK 12.8 million a year ago. Revenue was SEK 0.721 million compared to SEK 12.8 million a year ago.

Net loss was SEK 37.07 million compared to SEK 159.79 million a year ago. Basic loss per share from continuing operations was SEK 0.23 compared to SEK 0.99 a year ago. Diluted loss per share from continuing operations was SEK 0.23 compared to SEK 0.99 a year ago.